Form 4: HealthEquity Executive Sells Shares in Recent Transaction
SEC Form 4 Filing
Delano Ladd, EVP and General Counsel at HealthEquity, sold 475 shares of common stock on January 7, 2025.
Summary
- Delano Ladd, an executive at HealthEquity, sold 475 shares of the company's common stock.
- The transaction occurred on January 7, 2025.
- The sale price was $97.5445 per share.
- Following the transaction, Mr. Ladd directly owns 63,502 shares of HealthEquity stock.
Sentiment
Score: 5
Explanation: The document is a neutral report of an insider stock sale, with no indication of positive or negative sentiment.
Industry Context
This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the industry.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider trading activity.
- Similar filings are made by executives at companies like UnitedHealth Group (UNH) and CVS Health (CVS) when they trade their company's stock.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale by an executive.
Key Dates
| Date | Description |
|---|---|
| 01/07/2025 | Date of the stock sale transaction. |
| 01/10/2025 | Date the Form 4 was signed. |
Keywords
HealthEquity, HQY, stock sale, insider transaction, Delano Ladd, executive, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.